an oncology company, which focused on developing novel targeted therapies and engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment.
Industry Biotechnology
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EFV | 53.96 | 0.23 | +0.42% |
iShares MSCI EAFE Value ETF | |||
EVX | 183.52 | -1.12 | -0.61% |
VanEck Environmental Svcs ETF | |||
PJUL | 40.84 | -0.25 | -0.61% |
Innovator U.S. Equity Power BffrETF™-Jul | |||
TDV | 75.61 | -1.42 | -1.85% |
ProShares S&PTech Div Arstcrts ETF | |||
GDOC | 32.42 | -1.03 | -3.07% |
Goldman Sachs Future Health Care Eq ETF |
A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with KYMR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then KYMR could also see price increases.
Ticker / NAME | Correlation To RVMD | 1D Price Change % | ||
---|---|---|---|---|
RVMD | 100% | -3.90% | ||
KYMR - RVMD | 47% Loosely correlated | -8.67% | ||
ERAS - RVMD | 46% Loosely correlated | -4.98% | ||
PGEN - RVMD | 45% Loosely correlated | -7.11% | ||
IDYA - RVMD | 45% Loosely correlated | -9.60% | ||
RCKT - RVMD | 43% Loosely correlated | -5.67% | ||
More |